Competing interests DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work
Schedule your consultation to discuss your aesthetic goals BOOK CONSULTATION
While not yet commercially available, the retatrutide availability timeline suggests it could enter the market within the next few years
It's a supportive therapy for different health conditions and a booster for your immune system
The plasma half-life is about 58 h, but the plasma concentrations vary considerably between individuals [67, 68]
Regular meal patterns: Eating at consistent times helps manage blood sugar and hunger levels